3-Methyl-benzo[g]quinoline-5,10-dione

ID: ALA172953

PubChem CID: 10466152

Max Phase: Preclinical

Molecular Formula: C14H9NO2

Molecular Weight: 223.23

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cnc2c(c1)C(=O)c1ccccc1C2=O

Standard InChI:  InChI=1S/C14H9NO2/c1-8-6-11-12(15-7-8)14(17)10-5-3-2-4-9(10)13(11)16/h2-7H,1H3

Standard InChI Key:  DCGFZAUMBPWUPM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 19  0  0  0  0  0  0  0  0999 V2000
   -5.4900  -19.8026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4912  -20.6258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7799  -21.0366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7817  -19.3920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0700  -19.7991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0712  -20.6279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3580  -21.0410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3556  -19.3834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3555  -18.5626    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3603  -21.8618    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6379  -19.7902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6408  -20.6274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9183  -21.0467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1925  -20.6299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1937  -19.7894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9168  -19.3739    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4818  -21.0406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  7 12  1  0
 11  8  1  0
  5  4  2  0
  8  9  2  0
  4  1  1  0
  7 10  2  0
  5  6  1  0
 11 12  2  0
  2  3  1  0
 12 13  1  0
  3  6  2  0
 13 14  2  0
  1  2  2  0
 14 15  1  0
  5  8  1  0
 15 16  2  0
 16 11  1  0
  6  7  1  0
 14 17  1  0
M  END

Alternative Forms

Associated Targets(Human)

SNU1 (253 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNU-354 (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Raji (5516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 223.23Molecular Weight (Monoisotopic): 223.0633AlogP: 2.17#Rotatable Bonds:
Polar Surface Area: 47.03Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.81CX LogP: 2.60CX LogD: 2.60
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.59Np Likeness Score: 0.15

References

1. Lee H, Hong S, Kim Y.  (1996)  Synthesis and in vitro evaluation of 3-substituted-1-azaanthraquinones,  (8): [10.1016/0960-894X(96)00156-4]
2. Konoshima T, Kozuka M, Koyama J, Okatani T, Tagahara K, Tokuda H..  (1989)  Studies on inhibitors of skin tumor promotion, VI. Inhibitory effects of quinones on Epstein-Barr virus activation.,  52  (5): [PMID:2558164] [10.1021/np50065a012]

Source